3+ AI agents with strictly opposing mandates argue your investment thesis — a Judge synthesizes the debate into a consensus score and an institutional, MiFID II compliant verdict.
From adversarial stock debates to full investment committee simulations — every mode ends with a Judge synthesis and a documented verdict.
Adversarial investment debate — bullish vs bearish thesis, 2 rounds + Judge synthesis.
Investment Committee simulation — multi-partner deliberation with a final Chair decision.
Adversarial stress test — a Red Team agent attacks your primary thesis to find every fatal flaw.
Analyst vs Compliance Officer — the compliance agent holds real veto power over the recommendation.
Side-by-side diff of two agent or model outputs — perfect for benchmarking Claude vs Gemini vs GPT.
Whichever mode you choose, you get a defensible, documented verdict.
Run Bull vs Bear on any ticker before opening a position — get both sides argued at institutional depth in under a minute.
Simulate your Investment Committee before the real meeting — surface objections from Risk and dissenting Partners early.
Send your best investment thesis to the Red Team before you commit capital — find the fatal flaw before the market does.
Compliance Gate mode gives your Compliance Officer agent real veto power over any recommendation before it goes out.
Run Peer Review to compare Claude Sonnet 4.6 vs Gemini vs GPT outputs on the same prompt — side by side, with a diff.
Export any debate's Judge synthesis directly into a formatted IC Memo via the built-in DocGen integration.
A structured debate, not a single-shot AI answer.
Pick one of 5 debate modes and describe your thesis — add supporting context, data or filings if you have them.
Agents argue independently, then cross-challenge each other's weakest points in a second round — streamed in real time.
The Judge delivers a consensus score, a fair value estimate and a MiFID II compliant verdict — ready to export or share.
Learn from the workflows, tips and best practices shared across our Learning Paths — curated from what our community reads the most.
Every serious investment decision deserves a debate. Let Mextyl's agents argue it out — and give you a defensible, documented verdict every time.
Mextyl
When you visit our website, it may store or retrieve information in your browser, mostly in the form of cookies. This information may be about you, your preferences or your device and is used to make the site work as expected. It does not usually identify you directly, but it helps us provide a more relevant experience. You can choose not to allow certain types of cookies below. Blocking some categories may impact the site's functionality.